Good morning :)
$
₹
Mentari Therapeutics, Inc.

Mentari Therapeutics, Inc.

MTRI

NASDAQ
$16.0431.50% (+3.84)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Unknown

Recent listing (market-cap unavailable as on date)

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

—
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

P/E Ratio
27.65
27.65
1Y Return
12.56%
12.56%
Buy Reco %
94.44
94.44
P/E Ratio
27.62
27.62
1Y Return
15.48%
15.48%
Buy Reco %
54.16
54.16
P/E Ratio
79.57
79.57
1Y Return
8.16%
8.16%
Buy Reco %
90.90
90.90
P/E Ratio
31.33
31.33
1Y Return
17.43%
17.43%
Buy Reco %
86.95
86.95
P/E Ratio
18.36
18.36
1Y Return
1.09%
1.09%
Buy Reco %
52.63
52.63
Compare with Peers

Forecast

Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

Financials

Financials

Income

Balance Sheet

Cash Flow

164.1
43.5
361.6
-22.5
200
45.7
217.9
-10.3
Q2 2010
Q3 2010
Q4 2010
Q1 2011
Revenue
Net Income
Financial YearQ2 2010Q3 2010Q4 2010Q1 2011
Total Revenue164.18361.68200.05217.97
Net Income43.51-22.5745.73-10.39
Net Profit Margin26.50%-6.24%22.86%-4.76%

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Mentari Therapeutics, Inc. -0-
BlackRock Inc27.653.130.97
Blackstone Group Inc27.6210.811.17

Price Comparison

Price Comparison

Compare MTRI with any stock or ETF
Compare MTRI with any stock or ETF
Comparing from
MTRI
BLK
BX
Loading...

Frequently asked questions

  1. Mentari Therapeutics, Inc. (MTRI) share price today is $16.04 as of November 12, 2026 at 2:29 AM IST. The stock touched a day high of $16.39 and a day low of $13.37.

  2. Mentari Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol MTRI.

  3. Mentari Therapeutics, Inc.'s market capitalization is N/A as of November 12, 2026 at 2:29 AM IST.

  4. Mentari Therapeutics, Inc.'s price-to-earnings (P/E) ratio is N/A as of November 11, 2026.

  5. Mentari Therapeutics, Inc.'s price-to-book (P/B) ratio is 0 as of November 11, 2026.

  6. Yes, You can buy Mentari Therapeutics, Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Mentari Therapeutics, Inc. shares in three steps: 1. Search Mentari Therapeutics, Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Mentari Therapeutics, Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Mentari Therapeutics, Inc. (MTRI) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.6232 shares at the current price of $16.04.

Loading...